Adenosine triphosphate (CED0000774)

Record Information
Version1.0
Creation Date2014-08-29 06:12:10 UTC
Update Date2026-05-14 16:24:27 UTC
SynCED IDCED0000774
Secondary Accession Numbers
  • CHEM003236
  • T3D4276
Identification
Common NameAdenosine triphosphate
ClassSmall Molecule
Description
Adenosine triphosphate (C10H16N5O13P3) is an endogenous compound that exists as a solid at room temperature. Adenosine triphosphate belongs to the purine ribonucleotides, a subclass of purine nucleotides within the organic compounds. With an average molecular weight of 507.18 g/mol, Adenosine triphosphate is a heavy molecule. Biologically, it serves as a fundamental metabolite, micronutrient, cofactor (PMC12261052 , PMC6071185 ), and neurotransmitter (PMC4034482 ). Industrially, it is used as a softener and conditioner, and it finds application as a nutraceutical. It is detected in various tissues, including the bladder, kidney, pancreas, platelet, intestine, adipose tissue, myelin, nerve cells, neuron, muscle, skeletal muscle, and fibroblasts. The compound interacts with 42 recorded protein targets, including the ALK tyrosine kinase receptor, Phospholipid-transporting ATPase ABCA1, Acetyl-coenzyme A synthetase, cytoplasmic (ACSS2), and Tyrosine-protein kinase ABL2. Adenosine triphosphate is released from various sources, including household cleaning and consumer products (such as soap detergents, bleaching agents, and perfumes within detergents and soaps), food processing and cookware (including the preparation of vinegar, wine or sparkling wine, and the processing of meats and fish), tobacco smoke filters, and electrical and electronic equipment (including antennas, amplifiers, electric switches, electric hearing aids, and conductive bodies). Health effects associated with the compound include inflammation (PMC7555848 , PMC7609673 ), necrosis (PMC3004475 ), pain (PMC10556381 ), melanoma (PMC13053802 ), neuropathy (PMC11942409 ), interstitial cystitis (PMC11942409 ), and neuropathic pain (PMC11942409 ). Blood concentrations are decreased in hyperglycemia (PMC9712222 ), Alzheimer's disease (PMC9476395 ), colorectal cancer (PMC9321504 ), stroke (PMC3004475 ), ischemia (PMC3004475 ), amyotrophic lateral sclerosis (PMC10579595 ), multiple sclerosis (PMC9960436 ), and endometriosis (PMC8022091 , PMC13254854 ). In stroke, levels are decreased in the blood, cerebrospinal fluid, urine, and feces (PMC3004475 ). Increased levels are associated with pancreatic cancer (PMC8069343 ). Additionally, it is used as a treatment for drowsiness (PMC12517424 ).
Contaminant Type
  • Amine
  • Animal Toxin
  • Dietary Supplement
  • Drug
  • Ether
  • Food Toxin
  • Metabolite
  • Micronutrient
  • Natural Compound
  • Nutraceutical
  • Organic Compound
  • Supplement
Chemical Structure
Synonyms
ValueSource
Adenosine 5'-triphosphateChEBI
Adenosine-5'-triphosphateChEBI
AdephosChEBI
AdetolChEBI
AdynolChEBI
AtipiChEBI
AtriphosChEBI
CardenosineChEBI
FosfobionChEBI
GlucobasinChEBI
H4ATPChEBI
MyotriphosChEBI
TriadenylChEBI
TriphosphadenChEBI
Adenosine 5'-triphosphoric acidGenerator
Adenosine triphosphoric acidGenerator
ADENOSINE-5'-triphosphoric acidGenerator
5'-(Tetrahydrogen triphosphate) adenosineHMDB
5'-ATPHMDB
Adenosine 5'-triphosphorateHMDB
AdenylpyrophosphorateHMDB
Adenylpyrophosphoric acidHMDB
ATPHMDB, KEGG
PhosphobionHMDB
StriadyneHMDB, MeSH
Triphosphoric acid adenosine esterHMDB
AdenylpyrophosphateMeSH, HMDB
5’-ATPHMDB
Adenosine 5’-triphosphateHMDB
Adenosine 5’-triphosphoric acidHMDB
Adenosine triphosphateHMDB
Adenosine-5’-triphosphateHMDB
Chemical FormulaC10H16N5O13P3
Average Molecular Mass507.181 g/mol
Monoisotopic Mass506.996 g/mol
CAS Registry Number56-65-5
IUPAC Name({[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)phosphonic acid
Traditional Nameadenosine triphosphate
SMILESNC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O
InChI IdentifierInChI=1S/C10H16N5O13P3/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(26-10)1-25-30(21,22)28-31(23,24)27-29(18,19)20/h2-4,6-7,10,16-17H,1H2,(H,21,22)(H,23,24)(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1
InChI KeyZKHQWZAMYRWXGA-KQYNXXCUSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as purine ribonucleoside triphosphates. These are purine ribobucleotides with a triphosphate group linked to the ribose moiety.
KingdomOrganic compounds
Super ClassNucleosides, nucleotides, and analogues
ClassPurine nucleotides
Sub ClassPurine ribonucleotides
Direct ParentPurine ribonucleoside triphosphates
Alternative Parents
Substituents
  • Purine ribonucleoside triphosphate
  • Purine ribonucleoside monophosphate
  • Pentose phosphate
  • Pentose-5-phosphate
  • Glycosyl compound
  • N-glycosyl compound
  • 6-aminopurine
  • Monosaccharide phosphate
  • Pentose monosaccharide
  • Imidazopyrimidine
  • Purine
  • Aminopyrimidine
  • Monoalkyl phosphate
  • Monosaccharide
  • N-substituted imidazole
  • Organic phosphoric acid derivative
  • Phosphoric acid ester
  • Imidolactam
  • Alkyl phosphate
  • Pyrimidine
  • Azole
  • Tetrahydrofuran
  • Imidazole
  • Heteroaromatic compound
  • Secondary alcohol
  • 1,2-diol
  • Organoheterocyclic compound
  • Azacycle
  • Oxacycle
  • Organooxygen compound
  • Hydrocarbon derivative
  • Organic nitrogen compound
  • Organic oxide
  • Organopnictogen compound
  • Amine
  • Primary amine
  • Organic oxygen compound
  • Alcohol
  • Organonitrogen compound
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External Descriptors
Biological Properties
StatusDetected and Not Quantified
OriginEndogenous
Cellular Locations
  • Cytoplasm
  • Endoplasmic reticulum
  • Extracellular
  • Membrane
  • Mitochondria
  • Nucleus
  • Peroxisome
Biofluid LocationsNot Available
Tissue Locations
  • Adipose Tissue
  • Bladder
  • Fibroblasts
  • Intestine
  • Kidney
  • Muscle
  • Myelin
  • Nerve Cells
  • Neuron
  • Pancreas
  • Platelet
  • Skeletal Muscle
Applications
Biological Roles
Chemical RolesNot Available
Organoleptic EffectsNot Available
Physical Properties
StateSolid
AppearanceWhite powder.
Experimental Properties
PropertyValue
Melting Point176°C
Boiling PointNot Available
Solubility1E+006 mg/L
Predicted Properties
PropertyValueSource
Water Solubility4.49 g/LALOGPS
logP-0.84ALOGPS
logP-5.8ChemAxon
logS-2ALOGPS
pKa (Strongest Acidic)0.9ChemAxon
pKa (Strongest Basic)4.01ChemAxon
Physiological Charge-3ChemAxon
Hydrogen Acceptor Count14ChemAxon
Hydrogen Donor Count7ChemAxon
Polar Surface Area279.13 ŲChemAxon
Rotatable Bond Count8ChemAxon
Refractivity95.81 m³·mol⁻¹ChemAxon
Polarizability38.92 ųChemAxon
Number of Rings3ChemAxon
BioavailabilityNoChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
Spectra
Spectra
Spectrum TypeDescriptionSplash KeyDeposition DateView
Predicted GC-MSPredicted GC-MS Spectrumsplash10-004j-9785600000-9d385d54b8bf3d01c79aNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS Spectrumsplash10-0f7a-2129514000-9059f6c87291f92b0cb5Not AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0a4i-0131190000-316dbdca27f38ad8ee57Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-004i-0000900000-f5ffc4694dfd302fd52dNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0a4i-0000900000-e9a09b9360491c310280Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-004i-0000900000-f5ffc4694dfd302fd52dNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0a4i-0000900000-e9a09b9360491c310280Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-03di-0003900000-82c389314f7350fab875Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0a4i-0100190000-922e5f751812c8bd89bcNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-0901420000-44d898eb6218dc6e081fNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-0900100000-b93a7d45ee103ceb59b6Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-0900000000-296ded2a98ed98f22450Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-0900000000-9349def51790b33b6323Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-1900000000-049985fb880827a0d9a4Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-1900000000-1d79fc72baa703a816cfNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-2900000000-136ea397740616434de7Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-014r-4900000000-e53bae9d9851c94179c8Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-014i-9700000000-76dacfdda05972956c70Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-014i-9200000000-4ca00afb7e2831eedaa2Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-014i-9000000000-7208de8d2446aa0799e2Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-03di-0002900000-39bf04fe36582d191561Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-0900000000-4fd870751e7a7c9ed049Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-01qj-0589000000-e8436653012312014914Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-014i-0900000000-2ed6ad02e9674fa231efNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000j-0907000000-2b4301800311392b8d92Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-03di-0295000000-f2a7cb18b1b974e27173Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-004i-0001090000-50e30249a68a61072682Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-004i-3049050000-cd068ebd4533ae660f08Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0002-5291000000-4accb3670e23a6edcef5Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0002-7490000000-130aa6bec2024713be45Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0f72-9560000000-737a2c9b641f5a8fa253Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000b-9620000000-6363362c4d3e3cfaeed2Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-00kk-9700000000-910164814dbe4d6fb522Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-014s-9800000000-47dcd096bdf7b2fc40f2Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-014i-9700000000-9705543e1249581605eaNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-014i-9400000000-dd73a6c2983cb3ca700dNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-014i-9100000000-52f6c060b770c70ee4b9Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-014i-9000000000-bd7acefc2a1743ca293dNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-004i-0039000000-6e904e0650b131037f89Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0uxr-0190000000-13a5752559251c80c843Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-00di-0900000000-ffdcca5bd2b965040c67Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000j-0900000000-f48b7028d872bb471c9cNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000t-0090000000-38947932f74b2ba839ffNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0udi-0190000000-56164671cf10db39b4aaNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-004i-0009000000-383226a246453f1bd6c6Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000t-0090000000-1a7eb1db84cbb59733ffNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-00di-0000090000-483b380a7787079394ebNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-00di-0048980000-9577ad7c38d43e2b68a8Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-00dl-0069200000-d6833461d7351d6c4e35Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-006x-1689000000-a510ef4e1aa15b6eca02Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-00dl-2931000000-597175b990117d017c18Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-00di-2900000000-2eef6c2d27634782648eNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-00di-3900000000-46f839b309ae586bd461Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-00di-0026900000-fbae406809fcc2c1b0a4Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-002f-0090000000-370055d52f3601559340Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-004i-0090000000-be3971e57424172d1936Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-00di-0019000000-324961eeb39a8ce61d4aNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-004i-0091000000-fc18cd915da370224d3eNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-00dl-0029600000-ff44cb6e3e382ce3b3efNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-00di-0019000000-94069e1cc184dddcd2b6Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-004i-0930000000-79ce45aa281670d2faa2Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0udi-0000190000-a1198debb05d986f50f1Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0udi-0029440000-4570137c585226db6c1dNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0udi-0029000000-d02ac73fd763b0582426Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0udi-1459000000-45b42030dd5c8adf809aNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0uk9-2961000000-253d6152ec14a8a22ff9Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-00di-2910000000-f945f4f3700b95111be7Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-00di-2900000000-a3a52c18c0e8bd8afaa3Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-00y0-4900000000-380157db36d7f53572a0Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0fr2-0019500000-bb4915943e1b1dca6f2bNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0ue9-0069000000-a24d86627e4b270b1de4Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0udi-0090000000-d7a4b7756435bd948805Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0002-0009000000-f66a286dd0894fa965c7Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0udi-0090000000-c4d9e4877957059277c6Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-001i-0009000000-ef026d7f9ac3583a93ffNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-03di-0090000000-cd5829c65f2e80ab4be0Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0a4i-1910300000-001bbddf715e5b6dbb04Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0a4i-0100090000-c124163d08539fc4cafeNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0a4i-0910860000-42a9112a9f2c4c292c7bNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0a4i-2910100000-d6a2f8aafa6412aa65c5Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-000i-0911310000-f883981fb555288ec858Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-000i-0900000000-8ed3fe63c389ec26b73fNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-000i-1900000000-96bc47060403ae952c30Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0a59-0830290000-0774525fed54afda165aNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-001i-3930000000-a285e09b97437217cb03Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-004i-9300000000-7648d24e56aa73a5feb0Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0a4i-0000190000-0b85a4ef0caae606771fNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0k9i-0936240000-7154cd5cd74fed1d57f9Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-000i-0901000000-214969c4601986634dc7Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0a4i-0100090000-44874698a2bf8196122fNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-056r-9501440000-f609991832f69c60e2e6Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-004i-9100100000-5a010b04ed903651a090Not AvailableView Spectrum
1D NMR13C NMR Spectrum (1D, D2O, predicted)Not AvailableNot AvailableView Spectrum
1D NMR1H NMR Spectrum (1D, D2O, predicted)Not AvailableNot AvailableView Spectrum
1D NMR13C NMR Spectrum (1D, H2O, experimental)Not AvailableNot AvailableView Spectrum
Toxicity Profile
Toxicity Values
Toxicity ValueOrganismDose DescriptorRoute of ExposurePredicted or ExperimentalToxicity RatingReference
7012.0 Log mg/kg [3900:12000]RatLD50oralpredictedNot AvailableNot Available
Toxicity / Toxin ClassNot Available
Mechanism of ToxicityATP is able to store and transport chemical energy within cells. ATP also plays an important role in the synthesis of nucleic acids. ATP can be produced by various cellular processes, most typically in mitochondria by oxidative phosphorylation under the catalytic influence of ATP synthase. The total quantity of ATP in the human body is about 0.1 mole. The energy used by human cells requires the hydrolysis of 200 to 300 moles of ATP daily. This means that each ATP molecule is recycled 2000 to 3000 times during a single day. ATP cannot be stored, hence its consumption must closely follow its synthesis. Oral LD50 in rats is > 2 g/kg.
Carcinogenicity (IARC Classification)No indication of carcinogenicity to humans (not listed by IARC).
Minimum Risk LevelNot Available
SymptomsNot Available
TreatmentNot Available
Health Effects
Health EffectRelationshipDirectionDescriptionReference
inflammationAssociated With?Not AvailableNot AvailablePMC7555848 , PMC7609673
inflammationAssociated With?increaseNot AvailablePMC11621101
cancerAssociated With?Not AvailableCancer is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body. Possible signs and symptoms include a lump, abnormal bleeding, prolonged cough, unexplained weight loss, and a change in bowel movements. There are over 100 types of cancers affect humans. The risk of developing certain cancers can be reduced by not smoking, maintaining a healthy weight, not drinking too much alcohol, eating plenty of vegetables, fruits and whole grains, vaccination against certain infectious diseases, not eating too much processed and red meat and avoiding too much sunlight exposure. Cancer is often treated with some combination of radiation therapy, surgery, chemotherapy and targeted therapy. The majority of cancers, some 90–95% of cases, are due to genetic mutations from environmental and lifestyle factors. The remaining 5–10% are due to inherited genetics.PMC5624784
cancerDecreased in Blood InNot AvailableCancer is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body. Possible signs and symptoms include a lump, abnormal bleeding, prolonged cough, unexplained weight loss, and a change in bowel movements. There are over 100 types of cancers affect humans. The risk of developing certain cancers can be reduced by not smoking, maintaining a healthy weight, not drinking too much alcohol, eating plenty of vegetables, fruits and whole grains, vaccination against certain infectious diseases, not eating too much processed and red meat and avoiding too much sunlight exposure. Cancer is often treated with some combination of radiation therapy, surgery, chemotherapy and targeted therapy. The majority of cancers, some 90–95% of cases, are due to genetic mutations from environmental and lifestyle factors. The remaining 5–10% are due to inherited genetics.PMC4095669
drowsinessNot AvailableNot AvailableA state of sleepiness or lethargy.PMC12517424
Alzheimer's diseaseDecreased in Blood IndecreaseA neurodegenerative disease which causes neural atrophy, leading to dementia and memory loss.PMC9476395
Alzheimer's diseaseAssociated With?decreaseA neurodegenerative disease which causes neural atrophy, leading to dementia and memory loss.PMC10579595
multiple sclerosisAssociated With?decreaseA demyelinating disease that involves damage to the fatty myelin sheaths around the axons of the brain and spinal cord resulting in demyelination and scarring. (DO)PMC9960436
type 2 diabetes mellitusDecreased in Blood InNot AvailableNot AvailablePMC6878783 , PMC13288216
type 2 diabetes mellitusAssociated With?decreaseNot AvailablePMC13113401
colorectal cancerDecreased in Blood IndecreaseA large intestine cancer that is located in the colon and/or located in the rectum. (DO)PMC9321504
colorectal cancerDecreased in Blood InNot AvailableA large intestine cancer that is located in the colon and/or located in the rectum. (DO)PMC9321504
fatigueAssociated With?Not AvailableA disorder characterized by a state of generalized weakness with a pronounced inability to summon sufficient energy to accomplish daily activities. (NCI CTCAE)PMC13230977
diabetes mellitusDecreased in Blood IndecreaseA glucose metabolism disease characterized by chronic hyperglycaemia with disturbances of carbohydrate, fat and protein metabolism resulting from defects in insulin secretion, insulin action, or both. (DO)PMC5571204 , PMC6938787
diabetes mellitusAssociated With?Not AvailableA glucose metabolism disease characterized by chronic hyperglycaemia with disturbances of carbohydrate, fat and protein metabolism resulting from defects in insulin secretion, insulin action, or both. (DO)PMC4020716
strokeDecreased in Blood InNot AvailableNot AvailablePMC3004475
strokeDecreased in CSF InNot AvailableNot AvailablePMC3004475
strokeDecreased in Urine InNot AvailableNot AvailablePMC3004475
strokeDecreased in Feces InNot AvailableNot AvailablePMC3004475
neuropathic painAssociated With?Not AvailableNot AvailablePMC11942409
painAssociated With?Not AvailableA disorder characterized by the sensation of marked discomfort, distress or agony. (NCI CTCAE)PMC10556381 , PMC5257280
painAssociated With?increaseA disorder characterized by the sensation of marked discomfort, distress or agony. (NCI CTCAE)PMC11437851
hemolysisDecreased in Blood IndecreaseNot AvailablePMC7152208
melanomaAssociated With?Not AvailableA cell type cancer that has material basis in abnormally proliferating cells derives from melanocytes which are found in skin, the bowel and the eye. (DO)PMC13053802
chronic painAssociated With?Not AvailableA state in which pain lasts for several weeks or months and may increase in severity.PMC5624784
necrosisAssociated With?Not AvailableA disorder characterized as a form of cell injury which results in the premature death of cells in living tissue by autolysis.PMC3004475
necrosisDecreased in Blood InNot AvailableA disorder characterized as a form of cell injury which results in the premature death of cells in living tissue by autolysis.PMC7996528
necrosisDecreased in Blood IndecreaseA disorder characterized as a form of cell injury which results in the premature death of cells in living tissue by autolysis.PMC10856191
obesityAssociated With?increaseA disorder characterized by having a high amount of body fat. (NCI CTCAE)PMC8184480
heart failureAssociated With?decreaseA disorder characterized by the inability of the heart to pump blood at an adequate volume to meet tissue metabolic requirements, or, the ability to do so only at an elevation in the filling pressure. (NCI CTCAE)PMC12607619
seizureDecreased in Blood IndecreaseNot AvailablePMC7690410
hypoglycemiaAssociated With?Not AvailableA disorder characterized by laboratory test results that indicate a low concentration of glucose in the blood. (NCI CTCAE)PMC5533588
dental fluorosisAssociated With?increaseNot AvailablePMC9062983
neuropathyAssociated With?Not AvailableA nervous system disease that is located in nerves or nerve cells. (do).PMC11942409 , PMC11942409
neuropathyAssociated With?decreaseA nervous system disease that is located in nerves or nerve cells. (do).PMC10579595
ischemiaDecreased in Blood IndecreaseA disorder characterized by a decrease or absence of blood supply to an organ or tissue, caused by obstruction (thrombosis or embolism) of an artery. (NCI CTCAE)PMC3004475 , PMC11808734
amyotrophic lateral sclerosisAssociated With?decreaseA motor neuron disease that is characterized by muscle spasticity, rapidly progressive weakness due to muscle atrophy, difficulty in speaking, swallowing, and breathing. (DO)PMC10579595
hyperglycemiaDecreased in Blood IndecreaseA disorder characterized by laboratory test results that indicate an elevation in the concentration of blood sugar. It is usually an indication of diabetes mellitus or glucose intolerance. (NCI CTCAE)PMC9712222 , PMC13467452
Parkinson's diseaseAssociated With?decreaseA long-term degenerative disorder of the central nervous system that mainly affects the motor system. The symptoms generally come on slowly over time.PMC10579595 , PMC9267299
EndometriosisDecreased in Blood IndecreaseEndometriosis is a condition that affects women in which cells similar to those in the endometrium, the layer of tissue that normally covers the inside of the uterus, grow outside the uterus (mainly in the ovaries and fallopian tubes). The main symptoms are pelvic pain and infertility, although 20-25% of women are asymptomatic. Pain during sexual intercourse is also common. Other symptoms include diarrhea or constipation, chronic fatigue, nausea and vomiting, headaches, low-grade fevers, heavy and/or irregular periods, and hypoglycemia. Endometriosis is a common condition. About 6–10% of women are affected. Endometriosis is most common in those in their thirties and forties; however, it can begin in girls as early as eight years old.PMC8022091
EndometriosisAssociated With?decreaseEndometriosis is a condition that affects women in which cells similar to those in the endometrium, the layer of tissue that normally covers the inside of the uterus, grow outside the uterus (mainly in the ovaries and fallopian tubes). The main symptoms are pelvic pain and infertility, although 20-25% of women are asymptomatic. Pain during sexual intercourse is also common. Other symptoms include diarrhea or constipation, chronic fatigue, nausea and vomiting, headaches, low-grade fevers, heavy and/or irregular periods, and hypoglycemia. Endometriosis is a common condition. About 6–10% of women are affected. Endometriosis is most common in those in their thirties and forties; however, it can begin in girls as early as eight years old.PMC13254854
ovarian dysfunctionAssociated With?increaseNot AvailablePMC8184480
pancreatic cancerAssociated With?increaseAn endocrine gland cancer located in the pancreas. (DO)PMC8069343
neurodegenerative diseaseAssociated With?decreaseA central nervous system disease that results in the progressive deterioration of function or structure of neurons. (DO)PMC10579595
neurodegenerative diseaseDecreased in Blood IndecreaseA central nervous system disease that results in the progressive deterioration of function or structure of neurons. (DO)PMC3362933
neurodegenerative diseaseDecreased in Blood InNot AvailableA central nervous system disease that results in the progressive deterioration of function or structure of neurons. (DO)PMC4095669
hepatic steatosisDecreased in Blood InNot AvailableNot AvailablePMC8748349
cerebral infarctionAssociated With?Not AvailableAn ischemic condition of the brain, producing a persistent focal neurological deficit in the area of distribution of the cerebral arteries.PMC10457408
major depressive disorderDecreased in Blood IndecreaseAn endogenous depression that is characterized by an all-encompassing low mood accompanied by low self-esteem, and by loss of interest or pleasure in normally enjoyable activities. (DO)PMC3964743
Toxic encephalopathyAssociated With?Not AvailableNot AvailablePMC10514522 , PMC13290017
interstitial cystitisAssociated With?Not AvailableNot AvailablePMC11942409 , PMC8397461
interstitial cystitisElevated in Urine InincreaseNot AvailablePMC5257280
interstitial cystitisElevated in Blood InincreaseNot AvailablePMC9041750
status epilepticusDecreased in Blood IndecreaseNot AvailablePMC7690410
thyrotoxicosisAssociated With?Not AvailableNot AvailablePMC7870989
anovulationAssociated With?Not AvailableNot AvailablePMC13134263
Cell DeathDecreased in Blood InNot AvailableNot AvailablePMC8651694 , PMC4744107
Cell DeathAssociated With?Not AvailableNot AvailablePMC4428026 , PMC12347410
Cell DeathAssociated With?decreaseNot AvailablePMC8851132 , PMC12170717
Cell DeathDecreased in Blood IndecreaseNot AvailablePMC9028625 , PMC7080658
Cell DeathIs Biomarker OfNot AvailableNot AvailablePMC12108914
Abnormality of mitochondrial metabolismDecreased in Blood IndecreaseNot AvailablePMC10486742 , PMC10967835
Abnormality of mitochondrial metabolismAssociated With?Not AvailableNot AvailablePMC13259616 , PMC12678558
Abnormality of mitochondrial metabolismAssociated With?increaseNot AvailablePMC7546609 , PMC11748479
Abnormality of mitochondrial metabolismAssociated With?decreaseNot AvailablePMC4373491 , PMC11576129
Oxidative StressAssociated With?Not AvailableNot AvailablePMC13405123 , PMC7554266
Oxidative StressDecreased in Blood IndecreaseNot AvailablePMC13467452
Endoplasmic Reticulum StressAssociated With?Not AvailableNot AvailablePMC11140113
DNA DamageAssociated With?Not AvailableNot AvailablePMC3572937 , PMC11811701
disease by infectious agentAssociated With?Not AvailableNot AvailablePMC12669025
inflammatory diseaseAssociated With?Not AvailableNot AvailablePMC12362934
SepsisDecreased in Blood InNot AvailableNot AvailablePMC12935003 , PMC12935003
SepsisAssociated With?increaseNot AvailablePMC12935003
SepsisDecreased in Blood IndecreaseNot AvailablePMC12935003
prediabetes syndromeDecreased in Blood IndecreaseNot AvailablePMC5571204
DeathDecreased in Blood IndecreaseNot AvailablePMC2265061
muscular atrophyDecreased in Blood IndecreaseNot AvailablePMC8229249
FertilityAssociated With?decreaseNot AvailablePMC10608597 , PMC12609727
Microvesicular hepatic steatosisDecreased in Blood IndecreaseNot AvailablePMC4254931
infectious diseaseAssociated With?increaseNot AvailablePMC10532117
NeuroinflammationAssociated With?Not AvailableNot AvailablePMC11945920
ApoptosisDecreased in Blood InNot AvailableNot AvailablePMC7996528
ApoptosisDecreased in Blood IndecreaseNot AvailablePMC10856191
Cell SurvivalAssociated With?increaseNot AvailablePMC8126821
Cell SurvivalIs Biomarker OfNot AvailableNot AvailablePMC12685762
acute kidney injuryElevated in Blood InincreaseNot AvailablePMC12861575
Skin AgingDecreased in Blood IndecreaseNot AvailablePMC11766319
HypoxiaAssociated With?Not AvailableNot AvailablePMC10337955
HypoxiaDecreased in Blood InNot AvailableNot AvailablePMC4498934
HypoxiaDecreased in Blood IndecreaseNot AvailablePMC4498934 , PMC11641357
Drug Resistance, MultipleAssociated With?increaseNot AvailablePMC11322665
Drug Resistance, MultipleAssociated With?Not AvailableNot AvailablePMC3980875
fatty liver diseaseIs Biomarker OfNot AvailableNot AvailablePMC3856051
Neuronal loss in central nervous systemAssociated With?Not AvailableNot AvailablePMC8430734
aneuploidyAssociated With?increaseNot AvailablePMC12249650
Refractory drug responseAssociated With?Not AvailableNot AvailablePMC8607383
CytoprotectionAssociated With?Not AvailableNot AvailablePMC11610523
septic shockDecreased in Blood IndecreaseNot AvailablePMC6787199
Bladder painAssociated With?increaseNot AvailablePMC9571782
Sperm MotilityDecreased in Blood IndecreaseNot AvailablePMC12691394
Huntington's diseaseAssociated With?decreaseNot AvailablePMC10579595
inflammatory breast carcinomaDecreased in Blood IndecreaseNot AvailablePMC9321504 , PMC9321504
inflammatory breast carcinomaAssociated With?Not AvailableNot AvailablePMC9321504
acidosis disorderAssociated With?decreaseNot AvailablePMC3703868
dry eye syndromeDecreased in Blood IndecreaseNot AvailablePMC12590449
mitochondrial metabolism diseaseDecreased in Blood InNot AvailableNot AvailablePMC11521674
visceral painAssociated With?Not AvailableNot AvailablePMC7076962
Mitochondrial DiseasesAssociated With?Not AvailableNot AvailablePMC6525910
autosomal dominant cerebellar ataxiaAssociated With?decreaseNot AvailablePMC10579595
Rigor MortisDecreased in Blood InNot AvailableNot AvailablePMC12565842
Rigor MortisAssociated With?Not AvailableNot AvailablePMC12248625
mitochondrial diseaseDecreased in Blood InNot AvailableNot AvailablePMC4095669
bladder diseaseAssociated With?Not AvailableNot AvailablePMC5257280
Clouston syndromeAssociated With?increaseNot AvailablePMC11140265
Hermansky-Pudlak syndromeDecreased in Blood IndecreaseNot AvailablePMC12165736
Exposure Sources
Source IDSourceSectorReference
CEDs000010Insecticides?Insecticides are synthetic chemicals designed to control or eliminate insect pests that threaten crops and other agricultural products.Agriculture & land managementPubChem
CEDs000013Soil?Soil serves as a critical medium for plant growth and sustains various ecological functions; however, it can become a reservoir for synthetic chemical contamination.Agriculture & land managementPMC4596903 , PMC9804416
CEDs000050Groundwater?Groundwater serves as a vital resource for drinking water and agricultural irrigation but is increasingly susceptible to contamination from synthetic chemicals.Aquatic systems & sedimentsPMC7823482 , PMC182273
CEDs000070Stormwater runoff?Stormwater runoff refers to the flow of rainwater or melted snow that does not soak into the ground and instead collects pollutants as it travels over impervious surfaces such as roads and parking lots.Automotive & urban infrastructurePubChem
CEDs000115Drinking water?Drinking water can be a medium for synthetic chemical contamination, often originating from various industrial processes and agricultural practices.Drinking water & water supplyPMC12685762
CEDs000181Ballast water?Ballast water, taken on by ships to maintain stability and balance, often contains a diverse array of microorganisms, including bacteria, viruses, and plankton.Marine, shipping & aquaculturePubChem
CEDs000182Bilge water?Bilge water is a byproduct generated from the accumulation of water in the lowest part of a ship's hull, which may include a mixture of seawater, oil, fuel residues, and various contaminants.Marine, shipping & aquaculturePubChem
CEDs000233Brushes?Brushes used in personal care and cosmetics can be a source of synthetic chemical contamination due to the materials and coatings used in their manufacturing.Personal care & cosmeticsPubChem
CEDs000490Personal care & cosmeticsNot Available
CEDs000505Amplifiers?Amplifiers, commonly used in various electronic devices to enhance signal strength, can be a source of synthetic chemical contamination due to the materials and processes involved in their production and disposal.Electrical & Electronic EquipmentPubChem
CEDs000506Antennas?Antennas, commonly used in communication technologies, can be a source of synthetic chemical contamination through the materials and coatings used in their construction.Electrical & Electronic EquipmentPubChem
CEDs000511Conductors Or Conductive Bodies Characterised By The Conductive Materials?Conductors, or conductive bodies, are materials that allow the flow of electrical current, typically made from metals such as copper, aluminum, or silver.Electrical & Electronic EquipmentPubChem
CEDs000516Electric Hearing Aids?Electric hearing aids are small electronic devices designed to amplify sound for individuals with hearing loss.Electrical & Electronic EquipmentPubChem
CEDs000517Electric Switches?Electric switches, integral components in numerous devices, can be a source of synthetic chemical contamination due to the materials and manufacturing processes involved in their production.Electrical & Electronic EquipmentPubChem
CEDs000518Electrically Stimulated Smoking Devices?Electrically stimulated smoking devices, commonly known as e-cigarettes or vape pens, utilize electrical components to heat a liquid solution, often containing nicotine, flavorings, and other additives, to produce an aerosol for inhalation.Electrical & Electronic EquipmentPubChem
CEDs000519Electrodes?Electrodes, used in various electrical and electronic applications, can be a source of synthetic chemical contamination due to the materials from which they are constructed and the processes involved in their manufacturing.Electrical & Electronic EquipmentPubChem
CEDs000520Emergency Protective Devices?Emergency protective devices, such as circuit breakers and surge protectors, are essential components in electrical systems designed to prevent damage from overcurrent and surges.Electrical & Electronic EquipmentPubChem
CEDs000524Hybrid Capacitors?Hybrid capacitors are energy storage devices that combine the properties of electrolytic and supercapacitors, utilizing a combination of electrochemical principles to achieve higher energy density and power density.Electrical & Electronic EquipmentPubChem
CEDs000525Line Transmission Systems?Line Transmission Systems, commonly used for the distribution of electrical energy, can be a source of synthetic chemical contamination through the insulation materials and coatings utilized in their construction.Electrical & Electronic EquipmentPubChem
CEDs000530Radio Transmission Systems?Radio transmission systems utilize a variety of synthetic chemicals in their manufacturing and maintenance processes.Electrical & Electronic EquipmentPubChem
CEDs000531Relays?Relays are electromechanical switches used to control circuits and manage electrical loads.Electrical & Electronic EquipmentPubChem
CEDs000539Video Games?Video games, through their production and disposal processes, can be a source of synthetic chemical contamination.Electrical & Electronic EquipmentPubChem
CEDs000545Food Preservation?Food preservation often involves the use of synthetic chemicals, such as preservatives, flavor enhancers, and color additives, to extend shelf life and enhance the sensory qualities of food products.Food, food processing & cookwarePubChem
CEDs000548Preparation Of Vinegar?Vinegar is produced through the fermentation of ethanol by acetic acid bacteria, resulting in a solution that typically contains 4-8% acetic acid.Food, food processing & cookwarePubChem
CEDs000549Preparation Of Wine Or Sparkling Wine?The preparation of wine or sparkling wine involves various stages, including fermentation, aging, and bottling, which can introduce potential sources of synthetic chemical contamination.Food, food processing & cookwarePubChem
CEDs000551Processing Fish?Processing fish can lead to synthetic chemical contamination through various stages of production and preservation.Food, food processing & cookwarePubChem
CEDs000552Processing Meats?Processing meats can lead to synthetic chemical contamination primarily through the use of additives and preservatives.Food, food processing & cookwarePubChem
CEDs000555Bleaching Agents?Bleaching agents are chemical substances used to whiten or lighten materials, often employed in various cleaning products for their stain removal and disinfecting properties.Household cleaning & consumer productsPubChem
CEDs000561Perfumes Within Detergents And Soaps?Perfumes within detergents and soaps are synthetic fragrance compounds added to enhance the sensory experience of cleaning products.Household cleaning & consumer productsPubChem
CEDs000563Soap Detergents?Soap detergents are synthetic surfactants designed to enhance the cleaning efficacy of water by reducing surface tension, allowing for better interaction with dirt and grease.Household cleaning & consumer productsPubChem
CEDs000569Tobacco Smoke Filters?Tobacco smoke filters are designed to reduce the inhalation of harmful substances in cigarette smoke, including tar and other particulate matter.Household cleaning & consumer productsPubChem
CEDs000579Manufacture Of Iron Or Steel?The manufacture of iron or steel involves various processes, including smelting, refining, and alloying, which can result in the release of synthetic chemicals and contaminants.Industrial manufacturing & chemical processingPubChem
CEDs000580Manufacture Preparation Of Tobacco Products?The manufacture and preparation of tobacco products involve various processes that can result in the introduction of synthetic chemicals into the environment.Industrial manufacturing & chemical processingPubChem
CEDs000581Paper Making Machines?Paper making machines utilize various synthetic chemicals throughout the production process, including additives, coatings, and bleaching agents.Industrial manufacturing & chemical processingPubChem
CEDs000589Life Buoys?Life buoys, commonly used in marine environments for safety and rescue operations, can be a source of synthetic chemical contamination due to the materials used in their production.Marine, shipping & aquaculturePubChem
CEDs000596Acaricides?Acaricides are synthetic chemicals specifically designed to target and control mite populations that can damage crops and plants.Agriculture & land managementPubChem
CEDs000600Herbicides And Algicides?Herbicides and algicides are synthetic chemicals primarily used to control unwanted plants and algae in various environments.Agriculture & land managementPubChem
CEDs000603Nematocides?Nematocides are synthetic chemicals specifically designed to control nematodes, which are microscopic roundworms that can cause significant damage to crops and plants.Agriculture & land managementPubChem
CEDs000604Pest Attractants?Pest attractants are synthetic chemicals designed to lure specific pests for monitoring or control purposes.Agriculture & land managementPubChem
CEDs000606Plant Growth Regulators?Plant Growth Regulators (PGRs) are synthetic chemicals designed to influence the growth and development of plants.Agriculture & land managementPubChem
CEDs000607Rodenticides(1)?Rodenticides are synthetic chemicals specifically formulated to control rodent populations, serving as a crucial tool in managing pests that can damage crops and spread diseases.Agriculture & land managementPubChem
CEDs000608Rodenticides?Rodenticides are chemical substances specifically designed to control rodent populations by causing death through various mechanisms, including anticoagulation or neurotoxicity.Agriculture & land managementPubChem
CEDs000609Aftershave?Aftershave is a grooming product typically used to soothe and protect the skin following shaving.Personal care & cosmeticsPubChem
CEDs000610Aftersun Products?Aftersun products are designed to soothe and hydrate the skin after sun exposure, often containing various synthetic chemicals such as emollients, preservatives, and fragrances.Personal care & cosmeticsPubChem
CEDs000611Anti Perspirants Or Body Deoderants?Antiperspirants and body deodorants commonly contain synthetic chemicals such as aluminum compounds, parabens, and synthetic fragrances.Personal care & cosmeticsPubChem
CEDs000613Depilatories?Depilatories are products designed to remove unwanted hair through the application of synthetic chemicals that break down the protein structure of hair, facilitating its removal.Personal care & cosmeticsPubChem
CEDs000614Essential Oils Or Perfumes?Essential oils and perfumes are complex mixtures of volatile compounds derived from natural or synthetic sources, commonly used for their aromatic properties.Personal care & cosmeticsPubChem
CEDs000615Eye Makeup Products?Eye makeup products, including mascaras, eyeliners, and eyeshadows, often contain a variety of synthetic chemicals such as pigments, preservatives, and film-forming agents.Personal care & cosmeticsPubChem
CEDs000616Face Mask Cosmetics?Face mask cosmetics often contain a variety of synthetic chemicals, including preservatives, emulsifiers, and fragrances, which can contribute to chemical contamination.Personal care & cosmeticsPubChem
CEDs000617Lip Care Products?Lip care products, including lipsticks, balms, and glosses, often contain a variety of synthetic chemicals such as parabens, phthalates, and synthetic fragrances.Personal care & cosmeticsPubChem
CEDs000618Lip Makeup Products?Lip makeup products, such as lipsticks, lip glosses, and lip liners, often contain a variety of synthetic chemicals, including pigments, preservatives, and emollients.Personal care & cosmeticsPubChem
CEDs000619Manicure Pedicure?Manicure and pedicure procedures often involve the use of various synthetic chemicals, including solvents, nail polishes, and nail adhesives.Personal care & cosmeticsPubChem
CEDs000632Apparel?Apparel production often involves the use of various synthetic chemicals, including dyes, finishing agents, and preservatives.Textiles, leather & furnishingsPubChem
CEDs000640Embroidering And Tufting?Embroidering and tufting processes often involve the use of synthetic chemicals such as dyes, adhesives, and finishing agents.Textiles, leather & furnishingsPubChem
CEDs000642Footwear?Footwear production often involves the use of various synthetic chemicals, such as adhesives, dyes, and treatments, which can contribute to environmental contamination.Textiles, leather & furnishingsPubChem
CEDs000647Multicolour Dyeing?Multicolour dyeing involves the application of multiple synthetic dyes to textiles and other materials to achieve vibrant, diverse color patterns.Textiles, leather & furnishingsPubChem
CEDs000652Ropes?Ropes manufactured from synthetic fibers, such as polypropylene, nylon, and polyester, are widely used in various applications, including marine, construction, and outdoor activities.Textiles, leather & furnishingsPubChem
CEDs000655Slide Fasteners?Slide fasteners, commonly known as zippers, are mechanical devices used to join two edges of fabric or other materials.Textiles, leather & furnishingsPubChem
CEDs000662Yarns Or Threads?Yarns or threads used in textiles can be a source of synthetic chemical contamination due to the production processes and treatments they undergo.Textiles, leather & furnishingsPubChem
CEDs000664Fire Fighting Gels?Fire fighting gels are synthetic chemical formulations designed to enhance fire suppression effectiveness by creating a protective barrier against heat and flames.Fire suppression systems & agentsPubChem
CEDs000671Airplanes And Helicopters?Airplanes and helicopters are significant sources of synthetic chemical contamination primarily through the use of aviation fuels, lubricants, and de-icing agents.Aviation & AerospacePubChem
CEDs000673Unmanned Aerial Vehicles?Unmanned Aerial Vehicles (UAVs), commonly known as drones, utilize various synthetic chemicals in their manufacturing, operation, and maintenance processes.Aviation & AerospacePubChem
CEDs000678Nitrogenous Fertilisers?Nitrogenous fertilizers are synthetic chemical compounds primarily used to enhance plant growth by supplying essential nitrogen, a crucial nutrient for photosynthesis and protein synthesis.Agriculture & land managementPubChem
CEDs000679Phosphatic Fertilisers?Phosphatic fertilizers are synthetic chemical products primarily composed of phosphorus, which is essential for plant growth.Agriculture & land managementPubChem
CEDs000684Cements?Cements are a composite material primarily used as a binding agent in construction applications, formed by the calcination of limestone and clay minerals at high temperatures.Building & ConstructionPubChem
CEDs000685Ceramics?Ceramics can be a source of synthetic chemical contamination through various additives and processing agents used in their production.Building & ConstructionPubChem
CEDs000686Clay Wares?Clay wares are ceramic products made from natural clay, often utilized in various construction applications such as tiles, bricks, and sanitary ware.Building & ConstructionPubChem
CEDs000696Nanotechnology?Nanotechnology involves the manipulation of materials at the molecular or atomic level, typically within the range of 1 to 100 nanometers.Industrial manufacturing & chemical processingPubChem
CEDs000734Coating Compositions?Coating compositions, which include paints, sealants, and varnishes, are formulated with a variety of synthetic chemicals such as solvents, resins, pigments, and additives.Building & ConstructionPubChem
CEDs000735Explosives?Explosives are chemical compounds or mixtures designed to undergo rapid decomposition, releasing energy in the form of gas and heat.Defense & military infrastructurePubChem
CEDs000738Cooling Circuit Water?Cooling circuit water is utilized in various industrial processes to absorb and dissipate heat generated during operations.Industrial manufacturing & chemical processingPubChem
CEDs000739Inks?Inks are complex mixtures composed of pigments or dyes, solvents, resins, and additives used primarily for printing and writing applications.Paper, pulp & fiber productsPubChem
CEDs000740Paper?Paper production involves the processing of wood fibers and the use of various chemicals, which can lead to synthetic chemical contamination.Paper, pulp & fiber productsPubChem
CEDs000743Sludge Treatment?Sludge treatment involves the processing of waste materials generated from wastewater treatment plants, which often contain a variety of organic and inorganic substances.Wastewater, sanitation & biosolidsPubChem
CEDs000744Water, Wastewater, & Sewage Treatment?Water, wastewater, and sewage treatment processes are critical for managing and mitigating pollutants in water systems.Wastewater, sanitation & biosolidsPubChem
CEDs00782RhizosphereAgriculture & land managementPMC12737338
CEDs01144FoodFood, food processing & cookwarePMC7152397 , PMC4211008
CEDs01148MilkFood, food processing & cookwarePMC7465704
CEDs01171MeatFood, food processing & cookwarePMC6210272
CEDs01213FoodstuffsFood, food processing & cookwarePMC7152397
CEDs01244BeefFood, food processing & cookwarePMC12610265
CEDs01423Wheat RootsFood, food processing & cookwarePMC12609586
CEDs01532Food ResiduesFood, food processing & cookwarePMC7152397
CEDs01662UHT milkFood, food processing & cookwarePMC7152397
CEDs01879ResinIndustrial manufacturing & chemical processingPMC11550072
CEDs01947Olfactory EpitheliumIndustrial manufacturing & chemical processingPMC2966283
CEDs02255WaterAquatic systems & sedimentsPMC11127782 , PMC6112297
CEDs02264SedimentAquatic systems & sedimentsPMC242157
CEDs02270RiverAquatic systems & sedimentsPMC11916896
CEDs02286LakeAquatic systems & sedimentsPMC12685762
CEDs02620Cloud WaterAir, dust & atmospheric transportPMC9249623
CEDs02650RainAir, dust & atmospheric transportPMC12685762
CEDs03021Wastewater Treatment PlantWastewater, sanitation & biosolidsPMC13468172
CEDs03043WWTPsWastewater, sanitation & biosolidsPMC13468172
CEDs03191Detergent SolutionHousehold cleaning & consumer productsPMC2858361
CEDs03209Cotton FabricsTextiles, leather & furnishingsPMC9695412 , PMC9695412
CEDs03380Stainless SteelMining & metal processingPMC4211008
CEDs03397Carbon SteelMining & metal processingPMC3799508
Pathways
4611 pathwaysPathway Source: PathBank
Targets
StructureProteinUniProt IDOrganismRelationshipDetails
Glutamine--tRNA ligase structureClick to view 3D structureGlutamine--tRNA ligaseP00962Escherichia coli (strain K12)Predicted (SEA)
Prediction Confidence Score
0.676
Applicability Domain
0.676
Statistical Significance
1.00e-05
Supporting Reference Compounds
1
E-value
0.0778492
Adenylate cyclase structureClick to view 3D structureAdenylate cyclaseP94182Anabaena sp.KnownNot Available
Glutathione synthetase structureClick to view 3D structureGlutathione synthetaseP48637HumansKnownNot Available
SUMO-activating enzyme subunit 1 structureClick to view 3D structureSUMO-activating enzyme subunit 1Q9UBE0HumansKnownNot Available
Click to view 3D structureMonofunctional C1-tetrahydrofolate synthase, mitochondrialQ6UB35HumansKnownNot Available
Hexokinase-4 structureClick to view 3D structureHexokinase-4P35557HumansKnownNot Available
Click to view 3D structureEctonucleoside triphosphate diphosphohydrolase 8Q5MY95HumansKnownNot Available
ATP-dependent translocase ABCB1 structureClick to view 3D structureATP-dependent translocase ABCB1P08183HumansKnownNot Available
Ribose-phosphate pyrophosphokinase structureClick to view 3D structureRibose-phosphate pyrophosphokinaseP14193Bacillus subtilis (strain 168)KnownNot Available
Click to view 3D structureEctonucleoside triphosphate diphosphohydrolase 2Q9Y5L3HumansKnownNot Available
Click to view 3D structureEndoplasmic reticulum transmembrane helix translocaseQ9HD20HumansKnownNot Available
Adenylate kinase structureClick to view 3D structureAdenylate kinaseP16304Bacillus subtilis (strain 168)KnownNot Available
Guanine deaminase structureClick to view 3D structureGuanine deaminaseO34598Bacillus subtilis (strain 168)KnownNot Available
histidine kinase structureClick to view 3D structurehistidine kinaseO32393Arthrospira platensisKnownNot Available
Tyrosine-protein kinase CSK structureClick to view 3D structureTyrosine-protein kinase CSKP41240HumansKnownNot Available
Glutathione reductase structureClick to view 3D structureGlutathione reductaseP06715Escherichia coli (strain K12)KnownNot Available
Click to view 3D structurePhospholipid-transporting ATPase IBQ9NTI2HumansKnownNot Available
Caspase-1 structureClick to view 3D structureCaspase-1P29466HumansKnownNot Available
RalA-binding protein 1 structureClick to view 3D structureRalA-binding protein 1Q15311HumansKnownNot Available
Alkaline phosphatase structureClick to view 3D structureAlkaline phosphataseP00634Escherichia coli (strain K12)KnownNot Available
Phosphomevalonate kinase structureClick to view 3D structurePhosphomevalonate kinaseQ15126HumansKnownNot Available
Click to view 3D structureEctonucleoside triphosphate diphosphohydrolase 1P49961HumansKnownNot Available
Ketohexokinase structureClick to view 3D structureKetohexokinaseP50053HumansKnownNot Available
Hexokinase-1 structureClick to view 3D structureHexokinase-1P19367HumansKnownNot Available
Click to view 3D structurePlasma membrane calcium-transporting ATPase 2Q01814HumansKnownNot Available
Ribokinase structureClick to view 3D structureRibokinaseP0A9J6Escherichia coli (strain K12)KnownNot Available
Glutamate--cysteine ligase structureClick to view 3D structureGlutamate--cysteine ligaseP0A6W9Escherichia coli (strain K12)KnownNot Available
Adenosine deaminase structureClick to view 3D structureAdenosine deaminaseP00813HumansKnownNot Available
Glycerol kinase structureClick to view 3D structureGlycerol kinaseP0A6F3Escherichia coli (strain K12)KnownNot Available
Phosphoglycerate kinase structureClick to view 3D structurePhosphoglycerate kinaseP00560Saccharomyces cerevisiae S288cKnownNot Available
Pyruvate carboxylase structureClick to view 3D structurePyruvate carboxylaseA0A0H3JRU9Staphylococcus aureus (strain Mu50 / ATCC 700699)KnownNot Available
Corrinoid adenosyltransferase MMAB structureClick to view 3D structureCorrinoid adenosyltransferase MMABQ96EY8HumansKnownNot Available
Heat shock 70 kDa protein 1A structureClick to view 3D structureHeat shock 70 kDa protein 1AP0DMV8HumansKnownNot Available
Polyamine-transporting ATPase 13A2 structureClick to view 3D structurePolyamine-transporting ATPase 13A2Q9NQ11HumansKnownNot Available
Rhodopsin kinase GRK1 structureClick to view 3D structureRhodopsin kinase GRK1Q15835HumansKnownNot Available
Eukaryotic initiation factor 4A-II structureClick to view 3D structureEukaryotic initiation factor 4A-IIQ14240HumansKnownNot Available
5'-nucleotidase structureClick to view 3D structure5'-nucleotidaseP21589HumansKnownNot Available
Pannexin-1 structureClick to view 3D structurePannexin-1Q96RD7HumansKnownNot Available
Gap junction alpha-1 protein structureClick to view 3D structureGap junction alpha-1 proteinP17302HumansKnownNot Available
NAD kinase structureClick to view 3D structureNAD kinaseO95544HumansKnownNot Available
Riboflavin kinase structureClick to view 3D structureRiboflavin kinaseQ969G6HumansKnownNot Available
Inosine triphosphate pyrophosphatase structureClick to view 3D structureInosine triphosphate pyrophosphataseQ9BY32HumansKnownNot Available
Dual specificity tyrosine-phosphorylation-regulated kinase 1A structureClick to view 3D structureDual specificity tyrosine-phosphorylation-regulated kinase 1AQ13627HumansKnownNot Available
Xylulose kinase structureClick to view 3D structureXylulose kinaseO75191HumansKnownNot Available
U5 small nuclear ribonucleoprotein 200 kDa helicase structureClick to view 3D structureU5 small nuclear ribonucleoprotein 200 kDa helicaseO75643HumansKnownNot Available
DNA ligase structureClick to view 3D structureDNA ligaseP43813Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd)KnownNot Available
P2Y purinoceptor 12 structureClick to view 3D structureP2Y purinoceptor 12Q9H244HumansKnownNot Available
Pyruvate kinase structureClick to view 3D structurePyruvate kinaseC6KTA4Plasmodium falciparum (isolate 3D7)KnownNot Available
Sodium/potassium-transporting ATPase subunit alpha-3 structureClick to view 3D structureSodium/potassium-transporting ATPase subunit alpha-3P13637HumansKnownNot Available
Glutamine synthetase structureClick to view 3D structureGlutamine synthetaseP0A1P6Salmonella typhimurium (strain LT2 / SGSC1412 / ATCC 700720)KnownNot Available
Choline kinase structureClick to view 3D structureCholine kinaseQ8IM71Plasmodium falciparum (isolate 3D7)KnownNot Available
Click to view 3D structureAcetyl-coenzyme A synthetase, cytoplasmicQ9NR19HumansKnownNot Available
ATP-binding cassette sub-family C member 6 structureClick to view 3D structureATP-binding cassette sub-family C member 6O95255HumansKnownNot Available
Heat shock cognate 71 kDa protein structureClick to view 3D structureHeat shock cognate 71 kDa proteinP19120Bos taurusPredicted (SEA)
Prediction Confidence Score
0.981
Applicability Domain
0.981
Statistical Significance
1.00e-05
Supporting Reference Compounds
1
E-value
0.0778492
Cystic fibrosis transmembrane conductance regulator structureClick to view 3D structureCystic fibrosis transmembrane conductance regulatorP13569HumansKnownNot Available
Sensor protein kinase WalK structureClick to view 3D structureSensor protein kinase WalKQ9RDT3Staphylococcus aureusPredicted (SEA)
Prediction Confidence Score
0.981
Applicability Domain
0.981
Statistical Significance
1.00e-05
Supporting Reference Compounds
1
E-value
0.0778492
P2Y purinoceptor 1 structureClick to view 3D structureP2Y purinoceptor 1P47900HumansPredicted (SEA)
Prediction Confidence Score
0.945
Applicability Domain
1.0
Statistical Significance
1.00e-05
Supporting Reference Compounds
42
E-value
0.0778492
P2X purinoceptor 1 structureClick to view 3D structureP2X purinoceptor 1P51575HumansPredicted (SEA)
Prediction Confidence Score
0.932
Applicability Domain
1.0
Statistical Significance
1.00e-05
Supporting Reference Compounds
35
E-value
0.0778492
Click to view 3D structureP2Y purinoceptor 2P41231HumansPredicted (SEA)
Prediction Confidence Score
0.919
Applicability Domain
1.0
Statistical Significance
1.00e-05
Supporting Reference Compounds
44
E-value
0.0778492
Click to view 3D structureP2Y purinoceptor 1P49652Meleagris gallopavoPredicted (SEA)
Prediction Confidence Score
0.909
Applicability Domain
1.0
Statistical Significance
1.00e-05
Supporting Reference Compounds
19
E-value
0.0778492
P2X purinoceptor 3 structureClick to view 3D structureP2X purinoceptor 3P56373HumansPredicted (SEA)
Prediction Confidence Score
0.907
Applicability Domain
1.0
Statistical Significance
1.00e-05
Supporting Reference Compounds
51
E-value
0.0778492
Click to view 3D structureP2Y purinoceptor 12Q9EPX4Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.886
Applicability Domain
1.0
Statistical Significance
1.00e-05
Supporting Reference Compounds
11
E-value
0.0778492
ADP-ribose glycohydrolase MACROD1 structureClick to view 3D structureADP-ribose glycohydrolase MACROD1Q9BQ69HumansPredicted (SEA)
Prediction Confidence Score
0.875
Applicability Domain
0.875
Statistical Significance
1.00e-05
Supporting Reference Compounds
1
E-value
0.0778492
ADP-ribose glycohydrolase MACROD2 structureClick to view 3D structureADP-ribose glycohydrolase MACROD2A1Z1Q3HumansPredicted (SEA)
Prediction Confidence Score
0.875
Applicability Domain
0.875
Statistical Significance
1.00e-05
Supporting Reference Compounds
1
E-value
0.0778492
Click to view 3D structureP2Y purinoceptor 11Q96G91HumansPredicted (SEA)
Prediction Confidence Score
0.857
Applicability Domain
1.0
Statistical Significance
1.00e-05
Supporting Reference Compounds
13
E-value
0.0778492
Click to view 3D structureGTP:AMP phosphotransferase AK3, mitochondrialP29411Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.831
Applicability Domain
0.942
Statistical Significance
1.00e-05
Supporting Reference Compounds
2
E-value
0.0778492
Click to view 3D structureP2Y purinoceptor 1P49651Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.816
Applicability Domain
1.0
Statistical Significance
1.00e-05
Supporting Reference Compounds
9
E-value
0.0778492
P2X purinoceptor 4 structureClick to view 3D structureP2X purinoceptor 4Q99571HumansPredicted (SEA)
Prediction Confidence Score
0.808
Applicability Domain
1.0
Statistical Significance
1.00e-05
Supporting Reference Compounds
32
E-value
0.0778492
Biotin carboxylase structureClick to view 3D structureBiotin carboxylaseP24182Escherichia coli (strain K12)KnownNot Available
Click to view 3D structureS-adenosylmethionine synthase isoform type-2P18298Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.8
Applicability Domain
0.8
Statistical Significance
1.00e-05
Supporting Reference Compounds
1
E-value
0.0778492
Click to view 3D structureAdenylate kinase 2, mitochondrialP29410Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.755
Applicability Domain
0.942
Statistical Significance
1.00e-05
Supporting Reference Compounds
3
E-value
0.0778492
Ectonucleotide pyrophosphatase/phosphodiesterase family member 1 structureClick to view 3D structureEctonucleotide pyrophosphatase/phosphodiesterase family member 1P22413HumansPredicted (SEA)
Prediction Confidence Score
0.733
Applicability Domain
0.797
Statistical Significance
1.00e-05
Supporting Reference Compounds
29
E-value
0.0778492
Broad substrate specificity ATP-binding cassette transporter ABCG2 structureClick to view 3D structureBroad substrate specificity ATP-binding cassette transporter ABCG2Q9UNQ0HumansKnownNot Available
Click to view 3D structureP2X purinoceptor 2P49653Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.725
Applicability Domain
1.0
Statistical Significance
4.00e-05
Supporting Reference Compounds
38
E-value
0.311397
P2X purinoceptor 4 structureClick to view 3D structureP2X purinoceptor 4P51577Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.72
Applicability Domain
1.0
Statistical Significance
3.00e-05
Supporting Reference Compounds
31
E-value
0.233548
Glutamate dehydrogenase 1, mitochondrial structureClick to view 3D structureGlutamate dehydrogenase 1, mitochondrialP00366Bos taurusPredicted (SEA)
Prediction Confidence Score
0.705
Applicability Domain
0.71
Statistical Significance
1.00e-05
Supporting Reference Compounds
2
E-value
0.0778492
Click to view 3D structureP2X purinoceptor 6P51579Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.703
Applicability Domain
1.0
Statistical Significance
1.00e-05
Supporting Reference Compounds
5
E-value
0.0778492
Click to view 3D structureP2X purinoceptor 5P51578Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.703
Applicability Domain
1.0
Statistical Significance
1.00e-05
Supporting Reference Compounds
6
E-value
0.0778492
Kinesin-like protein KIFC1 structureClick to view 3D structureKinesin-like protein KIFC1Q9BW19HumansPredicted (SEA)
Prediction Confidence Score
0.689
Applicability Domain
1.0
Statistical Significance
1.00e-05
Supporting Reference Compounds
3
E-value
0.0778492
Click to view 3D structureP2X purinoceptor 2Q9UBL9HumansPredicted (SEA)
Prediction Confidence Score
0.678
Applicability Domain
0.793
Statistical Significance
1.00e-05
Supporting Reference Compounds
27
E-value
0.0778492
ATP-binding cassette sub-family G member 1 structureClick to view 3D structureATP-binding cassette sub-family G member 1P45844HumansKnownNot Available
ATP-dependent translocase ABCB1 structureClick to view 3D structureATP-dependent translocase ABCB1P08183HumansKnownNot Available
ATP-binding cassette sub-family C member 8 structureClick to view 3D structureATP-binding cassette sub-family C member 8Q09428HumansKnownNot Available
Click to view 3D structureAcetyl-coenzyme A synthetase, cytoplasmicQ9NR19HumansKnownNot Available
Phospholipid-transporting ATPase ABCA1 structureClick to view 3D structurePhospholipid-transporting ATPase ABCA1O95477HumansKnownNot Available
Click to view 3D structureATP-binding cassette sub-family C member 9O60706HumansKnownNot Available
Tyrosine-protein kinase ABL2 structureClick to view 3D structureTyrosine-protein kinase ABL2P42684HumansKnownNot Available
Apoptotic protease-activating factor 1 structureClick to view 3D structureApoptotic protease-activating factor 1O14727HumansKnownNot Available
ATP-binding cassette sub-family C member 2 structureClick to view 3D structureATP-binding cassette sub-family C member 2Q92887HumansKnownNot Available
Tyrosine-protein kinase ABL1 structureClick to view 3D structureTyrosine-protein kinase ABL1P00519HumansKnownNot Available
5'-AMP-activated protein kinase catalytic subunit alpha-1 structureClick to view 3D structure5'-AMP-activated protein kinase catalytic subunit alpha-1Q13131HumansKnownNot Available
Mitochondrial inner membrane m-AAA protease component AFG3L2 structureClick to view 3D structureMitochondrial inner membrane m-AAA protease component AFG3L2Q9Y4W6HumansKnownNot Available
ALK tyrosine kinase receptor structureClick to view 3D structureALK tyrosine kinase receptorQ9UM73HumansKnownNot Available
ATPase GET3 structureClick to view 3D structureATPase GET3O43681HumansKnownNot Available
Acetyl-coenzyme A synthetase 2-like, mitochondrial structureClick to view 3D structureAcetyl-coenzyme A synthetase 2-like, mitochondrialQ9NUB1HumansKnownNot Available
Activated CDC42 kinase 1 structureClick to view 3D structureActivated CDC42 kinase 1Q07912HumansKnownNot Available
Activin receptor type-1 structureClick to view 3D structureActivin receptor type-1Q04771HumansKnownNot Available
Activin receptor type-1B structureClick to view 3D structureActivin receptor type-1BP36896HumansKnownNot Available
Click to view 3D structureAdenylate cyclase type 1Q08828HumansKnownNot Available
Anti-Muellerian hormone type-2 receptor structureClick to view 3D structureAnti-Muellerian hormone type-2 receptorQ16671HumansKnownNot Available
Argininosuccinate synthase structureClick to view 3D structureArgininosuccinate synthaseP00966HumansKnownNot Available
Asparagine synthetase [glutamine-hydrolyzing] structureClick to view 3D structureAsparagine synthetase [glutamine-hydrolyzing]P08243HumansKnownNot Available
Beta-adrenergic receptor kinase 1 structureClick to view 3D structureBeta-adrenergic receptor kinase 1P25098HumansKnownNot Available
Click to view 3D structureG protein-coupled receptor kinase 3P35626HumansKnownNot Available
Bile salt export pump structureClick to view 3D structureBile salt export pumpO95342HumansKnownNot Available
Click to view 3D structureCyclin-dependent kinase 15Q96Q40HumansKnownNot Available
Cytosolic purine 5'-nucleotidase structureClick to view 3D structureCytosolic purine 5'-nucleotidaseP49902HumansKnownNot Available
Click to view 3D structureLong-chain-fatty-acid--CoA ligase 1P33121HumansKnownNot Available
Multidrug resistance-associated protein 1 structureClick to view 3D structureMultidrug resistance-associated protein 1P33527HumansKnownNot Available
NEDD8-activating enzyme E1 regulatory subunit structureClick to view 3D structureNEDD8-activating enzyme E1 regulatory subunitQ13564HumansKnownNot Available
Serine/threonine-protein kinase A-Raf structureClick to view 3D structureSerine/threonine-protein kinase A-RafP10398HumansKnownNot Available
Activin receptor type-1-like structureClick to view 3D structureActivin receptor type-1-likeP37023HumansKnownNot Available
Click to view 3D structureADP/ATP translocase 1P12235HumansKnownNot Available
Cystic fibrosis transmembrane conductance regulator structureClick to view 3D structureCystic fibrosis transmembrane conductance regulatorP13569HumansKnownNot Available
ATP-binding cassette sub-family C member 6 structureClick to view 3D structureATP-binding cassette sub-family C member 6O95255HumansKnownNot Available
Click to view 3D structureP2Y purinoceptor 11Q96G91HumansKnownNot Available
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform structureClick to view 3D structurePhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoformP42336HumansKnownNot Available
RAC-alpha serine/threonine-protein kinase structureClick to view 3D structureRAC-alpha serine/threonine-protein kinaseP31749HumansKnownNot Available
Concentrations
Not Available
External Links
DrugBank IDDB00171
HMDB IDHMDB0000538
FooDB IDFDB030683
Phenol Explorer IDNot Available
KNApSAcK IDC00001491
BiGG ID33477
BioCyc IDATP
METLIN ID5523
PDB IDNot Available
Wikipedia LinkAdenosine_triphosphate
Chemspider ID5742
ChEBI ID15422
PubChem Compound ID5957
Kegg Compound IDC00002
YMDB IDYMDB00109
ECMDB IDECMDB00538
References
Synthesis Reference

George M. Whitesides, Patricia E. Garrett, Merrell G. Siegel, “Method for preparing adenosine triphosphate.” U.S. Patent US4164444, issued April, 1975.

MSDSLink
General References
  1. Rutkowski B, Swierczynski J, Slominska E, Szolkiewicz M, Smolenski RT, Marlewski M, Butto B, Rutkowski P: Disturbances of purine nucleotide metabolism in uremia. Semin Nephrol. 2004 Sep;24(5):479-83. [PubMed: 15490415]
  2. Holzer AM, Granstein RD: Role of extracellular adenosine triphosphate in human skin. J Cutan Med Surg. 2004 Mar-Apr;8(2):90-6. Epub 2004 May 3. [PubMed: 15129319]
  3. Myburgh KH: Can any metabolites partially alleviate fatigue manifestations at the cross-bridge? Med Sci Sports Exerc. 2004 Jan;36(1):20-7. [PubMed: 14707763]
  4. Gartland A, Buckley KA, Hipskind RA, Bowler WB, Gallagher JA: P2 receptors in bone--modulation of osteoclast formation and activity via P2X7 activation. Crit Rev Eukaryot Gene Expr. 2003;13(2-4):237-42. [PubMed: 14696970]
  5. Di Virgilio F, Chiozzi P, Ferrari D, Falzoni S, Sanz JM, Morelli A, Torboli M, Bolognesi G, Baricordi OR: Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood. 2001 Feb 1;97(3):587-600. [PubMed: 11157473]
  6. Gajewski E, Steckler DK, Goldberg RN: Thermodynamics of the hydrolysis of adenosine 5'-triphosphate to adenosine 5'-diphosphate. J Biol Chem. 1986 Sep 25;261(27):12733-7. [PubMed: 3528161]
  7. Storer AC, Cornish-Bowden A: Concentration of MgATP2- and other ions in solution. Calculation of the true concentrations of species present in mixtures of associating ions. Biochem J. 1976 Oct 1;159(1):1-5. [PubMed: 11772]
  8. Wilson JE, Chin A: Chelation of divalent cations by ATP, studied by titration calorimetry. Anal Biochem. 1991 Feb 15;193(1):16-9. [PubMed: 1645933]
  9. Garfinkel L, Altschuld RA, Garfinkel D: Magnesium in cardiac energy metabolism. J Mol Cell Cardiol. 1986 Oct;18(10):1003-13. [PubMed: 3537318]
  10. Parsons M: Glycosomes: parasites and the divergence of peroxisomal purpose. Mol Microbiol. 2004 Aug;53(3):717-24. [PubMed: 15255886]
  11. Nakayama Y, Kinoshita A, Tomita M: Dynamic simulation of red blood cell metabolism and its application to the analysis of a pathological condition. Theor Biol Med Model. 2005 May 9;2:18. [PubMed: 15882454]
  12. Gottlieb C, Svanborg K, Eneroth P, Bygdeman M: Effect of prostaglandins on human sperm function in vitro and seminal adenosine triphosphate content. Fertil Steril. 1988 Feb;49(2):322-7. [PubMed: 3338588]
  13. Mahmoud AM, Comhaire FH, Vermeulen L, Andreou E: Comparison of the resazurin test, adenosine triphosphate in semen, and various sperm parameters. Hum Reprod. 1994 Sep;9(9):1688-93. [PubMed: 7836519]
  14. Kadmon M, Klunemann C, Bohme M, Ishikawa T, Gorgas K, Otto G, Herfarth C, Keppler D: Inhibition by cyclosporin A of adenosine triphosphate-dependent transport from the hepatocyte into bile. Gastroenterology. 1993 May;104(5):1507-14. [PubMed: 7683296]
  15. Sun Y, MaLossi J, Jacobs SC, Chai TC: Effect of doxazosin on stretch-activated adenosine triphosphate release in bladder urothelial cells from patients with benign prostatic hyperplasia. Urology. 2002 Aug;60(2):351-6. [PubMed: 12137852]
  16. Ryan LM, Rachow JW, McCarty BA, McCarty DJ: Adenosine triphosphate levels in human plasma. J Rheumatol. 1996 Feb;23(2):214-9. [PubMed: 8882021]
  17. Yoshida M, Miyamae K, Iwashita H, Otani M, Inadome A: Management of detrusor dysfunction in the elderly: changes in acetylcholine and adenosine triphosphate release during aging. Urology. 2004 Mar;63(3 Suppl 1):17-23. [PubMed: 15013648]
  18. Bar-Meir M, Elpeleg ON, Saada A: Effect of various agents on adenosine triphosphate synthesis in mitochondrial complex I deficiency. J Pediatr. 2001 Dec;139(6):868-70. [PubMed: 11743516]
  19. Mannucci L, Pastore A, Rizzo C, Piemonte F, Rizzoni G, Emma F: Impaired activity of the gamma-glutamyl cycle in nephropathic cystinosis fibroblasts. Pediatr Res. 2006 Feb;59(2):332-5. [PubMed: 16439602]
  20. Livingston JH, Brown JK, Harkness RA, McCreanor GM: Cerebrospinal fluid nucleotide metabolites following non-convulsive status epilepticus. Dev Med Child Neurol. 1989 Apr;31(2):168-73. [PubMed: 2737369]